menu search

RSPI / RespireRx Pharmaceuticals notes publication of paper on newest GABAkine analog which protects against seizures and lethality

RespireRx Pharmaceuticals notes publication of paper on newest GABAkine analog which protects against seizures and lethality
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc has noted the publication of a paper detailing the company's newest candidate D5-KRM-II-81, which is a so-called GABAkine - a type of medicine which enhances the inhibitory neurotransmitter in the brain. This latest asset is a structurally related analog to KRM-II-81, which, as previously reported, RespireRX's EndeavourRx business unit is advancing for the treatment of epilepsy and chronic pain. Read More
Posted: Mar 17 2022, 09:49
Author Name: Proactive Investors
Views: 103141

RSPI News  

RespireRx Pharmaceuticals' Australia cannabis subsidiary inks LOI securing $3.1M investment

By Proactive Investors
May 24, 2023

RespireRx Pharmaceuticals' Australia cannabis subsidiary inks LOI securing $3.1M investment

RespireRx Pharmaceuticals (OTC:RSPI) Inc subsidiary ResolutionRx Ltd entered into a binding letter of intent last week with Cantheon Capital, in whic more_horizontal

RespireRx Pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publications

By Proactive Investors
April 3, 2023

RespireRx Pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publications

RespireRx Pharmaceuticals (OTC:RSPI) Inc has announced the publication of four articles describing the pharmacological activity of novel structural an more_horizontal

RespireRx Pharmaceuticals appoints Joseph Siegelbaum as independent director on its board

By Proactive Investors
March 28, 2023

RespireRx Pharmaceuticals appoints Joseph Siegelbaum as independent director on its board

RespireRx Pharmaceuticals (OTC:RSPI) Ltd has announced the appointment of Joseph Siegelbaum to the company's board as an independent director, effect more_horizontal

RespireRx Pharmaceuticals' Australian subsidiary inks loan agreements to advance R&D for sleep apnea treatment

By Proactive Investors
February 1, 2023

RespireRx Pharmaceuticals' Australian subsidiary inks loan agreements to advance R&D for sleep apnea treatment

RespireRx Pharmaceuticals (OTC:RSPI) Inc announced that its recently created Australia-based subsidiary ResolutionRx Ltd has signed a letter of intent more_horizontal

RespireRx Pharmaceuticals strikes second amendment to its license agreement with the University of Illinois

By Proactive Investors
January 23, 2023

RespireRx Pharmaceuticals strikes second amendment to its license agreement with the University of Illinois

RespireRx Pharmaceuticals (OTC:RSPI) Inc revealed that the company and the Board of Trustees of University of Illinois (UIL), have agreed to a second more_horizontal

RespireRX Pharmaceuticals establishes ResolutionRX in Australia to advance its cannabinoid program

By Proactive Investors
January 12, 2023

RespireRX Pharmaceuticals establishes ResolutionRX in Australia to advance its cannabinoid program

RespireRx Pharmaceuticals (OTC:RSPI) Inc said that as of January 11, 2023, it has established a new, currently wholly-owned, unlisted public company i more_horizontal

RespireRx Pharmaceuticals joins NIH program to find non-opioid pain-relief mechanisms to combat addiction

By Proactive Investors
December 5, 2022

RespireRx Pharmaceuticals joins NIH program to find non-opioid pain-relief mechanisms to combat addiction

RespireRx Pharmaceuticals (OTC:RSPI) Inc announced that it has been accepted into the National Institute of Health's (NIH) Helping to End Addiction Lo more_horizontal

RespireRx Pharmaceuticals signs letter of intent with Australian CRO to study drug for treating obstructive sleep apnea

By Proactive Investors
November 17, 2022

RespireRx Pharmaceuticals signs letter of intent with Australian CRO to study drug for treating obstructive sleep apnea

RespireRx Pharmaceuticals (OTCQB:RSPI) said it has signed a letter of intent with a bespoke clinical research organization in Australia that focuses o more_horizontal


Search within

Pages Search Results: